First biosimilar of dornase alfa inhalation solution for CF approved in Russia, companies announce

19 September 2019 - A biosimilar of dornase alfa inhalation solution, with the same therapeutic activity as Pulmozyme, its reference ...

Read more →

Russia approves Spinraza to treat all SMA patients

29 August 2019 - Russia has become the first of the 15 former Soviet republics to approve Biogen’s Spinraza (nusinersen) ...

Read more →